Format
Sort by
Items per page

Send to

Choose Destination

Best matches for MK4305 OR Suvorexant OR "mk-4305":

Suvorexant for the Treatment of Insomnia in Adolescents. Kawabe K et al. J Child Adolesc Psychopharmacol. (2017)

Suvorexant: scientifically interesting, utility uncertain. Keks NA et al. Australas Psychiatry. (2017)

Suvorexant. et al. Aust Prescr. (2017)

Search results

Items: 10

  • Filters activated: Cancer. Clear all to show 197 items.
1.

[Usefulness of Suvorexant for Complicated Delirium in Cancer Patients Who Experience Sleep Disturbance during Hospitalization].

Kessoku T, Kusakabe A, Matsuura T, Honda Y, Yoshimi A, Goto A, Yoshida H, Sukegawa A, Hata C, Saito Y, Miyashita Y, Yashiro R, Komori T, Arai S, Nakajima A, Ichikawa Y.

Gan To Kagaku Ryoho. 2018 Mar;45(Suppl 1):92-94. Japanese.

PMID:
29650886
2.

CNS Drug Development, Lessons Learned, Part 4: The Role of Brain Circuitry and Genes-Tasimelteon as an Example.

Preskorn SH.

J Psychiatr Pract. 2017 Nov;23(6):425-430. doi: 10.1097/PRA.0000000000000274.

PMID:
29303950
3.

Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders.

Tsuneki H, Wada T, Sasaoka T.

Pharmacol Ther. 2018 Jun;186:25-44. doi: 10.1016/j.pharmthera.2017.12.010. Epub 2017 Dec 29. Review.

PMID:
29289556
4.

Neurobiological Basis of Hypersomnia.

Urade Y.

Sleep Med Clin. 2017 Sep;12(3):265-277. doi: 10.1016/j.jsmc.2017.03.003. Epub 2017 Jun 7. Review.

PMID:
28778226
5.

Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine.

Gentile TA, Simmons SJ, Watson MN, Connelly KL, Brailoiu E, Zhang Y, Muschamp JW.

Neuropsychopharmacology. 2018 Apr;43(5):1001-1009. doi: 10.1038/npp.2017.158. Epub 2017 Jul 25.

6.

Postoperative delirium after pharyngolaryngectomy with esophagectomy: a role for ramelteon and suvorexant.

Booka E, Tsubosa Y, Matsumoto T, Takeuchi M, Kitani T, Nagaoka M, Imai A, Kamijo T, Iida Y, Shimada A, Takebayashi K, Niihara M, Mori K, Onitsuka T, Takeuchi H, Kitagawa Y.

Esophagus. 2017;14(3):229-234. doi: 10.1007/s10388-017-0570-z. Epub 2017 Jan 21.

7.

Is suvorexant a better choice than alternative hypnotics?

Kripke DF.

F1000Res. 2015 Aug 3;4:456. doi: 10.12688/f1000research.6845.1. eCollection 2015.

8.

Pharmaceutical approval update.

Gohil K.

P T. 2014 Oct;39(10):684-94.

9.

The top 10 drug trends right now.

Johnson MS.

Nurs Manage. 2013 Jul;44(7):34-40; quiz 40-1. doi: 10.1097/01.NUMA.0000431421.08582.19. No abstract available.

PMID:
23764906
10.

Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist.

Winrow CJ, Gotter AL, Cox CD, Doran SM, Tannenbaum PL, Breslin MJ, Garson SL, Fox SV, Harrell CM, Stevens J, Reiss DR, Cui D, Coleman PJ, Renger JJ.

J Neurogenet. 2011 Mar;25(1-2):52-61. doi: 10.3109/01677063.2011.566953. Epub 2011 Apr 8. Erratum in: J Neurogenet. 2016 Sep - Dec;30(3-4):316.

PMID:
21473737

Supplemental Content

Loading ...
Support Center